PTC
BMRN icon

Private Trust Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

Private Trust Company’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14
Closed -$758 – 2558
2025
Q3 		$758 Buy
+14
New +$801 ﹤0.01% 2462
2024
Q4 		– Sell
-67
Closed -$4.71K – 2335
2024
Q3 		$4.71K Buy
67
+19
+40% +$1.59K ﹤0.01% 1964
2024
Q2 		$3.95K Hold
48
– – ﹤0.01% 2009
2024
Q1 		$4.19K Sell
48
-40
-45% -$3.58K ﹤0.01% 1977
2023
Q4 		$8.48K Sell
88
-550
-86% -$48.7K ﹤0.01% 1713
2023
Q3 		$56.5K Sell
638
-100
-14% -$8.9K 0.01% 968
2023
Q2 		$64K Hold
738
– – 0.01% 951
2023
Q1 		$71.8K Buy
738
+48
+7% +$4.98K 0.01% 883
2022
Q4 		$71K Hold
690
– – 0.01% 842
2022
Q3 		$58K Hold
690
– – 0.01% 840
2022
Q2 		$57K Buy
+690
New +$54.9K 0.01% 869
2014
Q4 		– Sell
-47
Closed -$3K – 404
2014
Q3 		$3K Sell
47
-225
-83% -$14.8K ﹤0.01% 1441
2014
Q2 		$17K Sell
272
-88
-24% -$5.32K 0.01% 882
2014
Q1 		$25K Sell
360
-12
-3% -$884 0.01% 678
2013
Q4 		$26K Buy
372
+187
+101% +$12.7K 0.01% 625
2013
Q3 		$13K Buy
185
+135
+270% +$8.97K 0.01% 800
2013
Q2 		$3K Buy
+50
New +$3.12K ﹤0.01% 1201

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Private Trust Company's BMRN Position: Q4 2025 in Review

Private Trust Company sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 14 shares — an estimated $758 sold.

Private Trust Company first reported a position in BMRN in Q2 2013 and held it in 17 quarters. The position peaked at $71.8K in Q1 2023. 540 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • Private Trust Company reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 14 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $758.
  • Private Trust Company first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Private Trust Company's BioMarin Pharmaceuticals position peaked at $71.8K in Q1 2023.
  • 540 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.